The fact that reelin is able to antagonize the deposition and toxicity of beta amyloid (Aβ) peptides in AD suggests the possibility of using inhibitors of ADAMTS-3 proteolytic activity to block reelin N-t cleavage. Here, RELN is linked to Alzheimer disease.